Study on the mechanism of Shujin Tongluo granules in treating cervical spondylosis based on network pharmacology and molecular docking

被引:1
|
作者
Wang, Yixuan [1 ]
Tao, Xiaoyu [1 ]
Gao, Yifei [1 ]
Jin, Zhengsen [1 ]
Guo, Siyu [1 ]
Li, Zhenjiang [2 ]
Wang, Mengmeng [3 ]
Zhao, Ruoqi [1 ]
Zhou, Wei [4 ]
Wu, Jiarui [1 ,5 ]
机构
[1] Beijing Univ Chinese Med, Sch Chinese Mat Med, Dept Clin Chinese Pharm, Beijing, Peoples R China
[2] Shineway Pharmaceut Grp Ltd, Shijiazhuang, Peoples R China
[3] World Federat Chinese Med Soc, Beijing, Peoples R China
[4] China Japan Friendship Hosp, Beijing, Peoples R China
[5] Beijing Univ Chinese Med, Sch Chinese Mat Med, Dept Clin Chinese Pharm, Beijing 102401, Peoples R China
基金
中国国家自然科学基金;
关键词
cervical spondylosis; mechanism of action; network pharmacology; Shujin Tongluo granules; PREDICTION;
D O I
10.1097/MD.0000000000034030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background:To investigate the potential active ingredients and possible mechanisms of Shujin Tongluo granules (SJTLG) in the treatment of cervical spondylosis (CS) by network pharmacology and molecular docking. Methods:The active ingredients and potential targets of SJTLG were obtained through databases such as traditional Chinese medicine system (TCMSP) and BATMAN-traditional Chinese medicine (TCM), and the relevant human targets of CS were identified through databases such as OMIM, GeneCards, and DisGeNET. The intersection targets were imported into STRING for protein-protein interaction (PPI) analysis. The obtained data were imported into Cytoscape 3.9.0 software for visualization, and module analysis was performed using the MCODE plug-in. The representative targets were screened through the Metascape website for pathway enrichment analysis in Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). Cytoscape software was used to build networks such as "drug-compound-target" and "drug-compound-target-pathway." Finally, the key targets were selected for molecular docking with the corresponding compounds by Autodock Tools 1.5.7 and visualized by PyMol. Results:A total of 132 active compounds and 996 targets from SJTLG and 678 targets from CS were screened with 116 intersection targets. The key targets were AKT1, GAPDH, ALB, IL-6, TP53, TNF, VEGFA, IL-1 & beta;, EGFR, HSP90AA1, ESR1, and JUN. The results of GO and KEGG enrichment analysis showed that the treatment of CS was mainly related to biological processes such as cellular response to nitrogen compound, cellular response to organonitrogen compound, and positive regulation of locomotion, and the targets were mainly focused on pathways in cancer, Kaposi sarcoma-associated herpesvirus infection, PI3K-Akt signaling pathway, lipid, and atherosclerosis. Molecular docking results showed that the minimum binding energy between the core targets and the corresponding compound was Conclusion:This study preliminarily elucidates the potential active ingredients and mechanism of anti-inflammatory, analgesic, microcirculation improvement, vasodilation, osteoporosis inhibition and nerve nutrition effects of SJTLG in the treatment of CS and provides a reference for its clinical application.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Mechanism of the Anti-Influenza Functions of Guizhi Granules Based on Network Pharmacology, Molecular Docking, and in Vitro Experiments
    Ling, Wei
    Li, Xiang
    Liu, Xiaoyu
    Wu, Qian
    Wang, Weilong
    Meng, Jin
    Sun, Baochang
    Lv, Binbin
    CHEMISTRY & BIODIVERSITY, 2023, 20 (05)
  • [42] Exploring the mechanism of action of Shuangyang houbitong granules in the treatment of acute pharyngitis based on network pharmacology and molecular docking
    Zhou, Jiying
    Qiao, Chuanqi
    Gao, Yifei
    Wang, Haojia
    Li, Jiaqi
    Yang, Siyun
    Chai, Keyan
    Zhao, Tong
    Wu, Jiarui
    MEDICINE, 2024, 103 (13) : E37674
  • [43] Network Pharmacology and Molecular Docking Elucidate the Pharmacological Mechanism of the OSTEOWONDER Capsule for Treating Osteoporosis
    Fan, Jiashuang
    Zhou, Jianli
    Qu, Zhuan
    Peng, Hangya
    Meng, Shuhui
    Peng, Yaping
    Liu, Tengyan
    Luo, Qiu
    Dai, Lifen
    FRONTIERS IN GENETICS, 2022, 13
  • [44] Exploring the mechanism of genistein in treating hepatocellular carcinoma through network pharmacology and molecular docking
    Wang, Siliang
    Chen, Wenlian
    Dong, Changsheng
    Wu, Jia
    Zheng, Miaomiao
    Ma, Yushui
    Xue, Yuwen
    ONCOLOGIE, 2024, 26 (05) : 799 - 811
  • [45] Network Pharmacology and Molecular Docking to Explore the Pharmacological Mechanism of the Zuojin Pill in Treating CAG
    Liu, Yantong
    Cao, Qi
    Ren, Shuang
    Li, Xiaochen
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (10): : 5653 - 5668
  • [46] Mechanism Study of Polydatin in Treating Spinal Cord Injury by Modulating Mitochondrial Membrane Potential Based on Network Pharmacology and Molecular Docking
    Dong, Bo
    He, Xijing
    CRITICAL REVIEWS IN IMMUNOLOGY, 2024, 44 (01) : 79 - 90
  • [47] Mechanism of Astragali Radix for the treatment of osteoarthritis: A study based on network pharmacology and molecular docking
    Shao, Yiming
    He, Jiao
    Zhang, Xinan
    Xie, Panpan
    Lian, Hongkai
    Zhang, Meng
    MEDICINE, 2022, 101 (28)
  • [48] Study on the multitarget mechanism of alliin activating autophagy based on network pharmacology and molecular docking
    Cheng, Bijun
    Li, Tianjiao
    Li, Fenglin
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2022, 26 (22) : 5590 - 5601
  • [49] Molecular mechanism of lycorine in the treatment of glioblastoma based on network pharmacology and molecular docking
    Jie Su
    Mengmeng Huo
    Fengnan Xu
    Liqiong Ding
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2024, 397 : 1551 - 1559
  • [50] Molecular mechanism of lycorine in the treatment of glioblastoma based on network pharmacology and molecular docking
    Su, Jie
    Huo, Mengmeng
    Xu, Fengnan
    Ding, Liqiong
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (03) : 1551 - 1559